Q2 2017 13F Holders as of 6/30/2017
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
124
-
Total 13F shares, excl. options
-
25.2M
-
Shares change
-
+153K
-
Total reported value, excl. options
-
$1.06B
-
Value change
-
+$7.82M
-
Put/Call ratio
-
1.14
-
Number of buys
-
50
-
Number of sells
-
-64
-
Price
-
$42.14
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q2 2017
146 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q2 2017.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 124 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.2M shares
of 835M outstanding shares and own 3.02% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (5.6M shares), ROYAL BANK OF CANADA (3.46M shares), COMMONWEALTH BANK OF AUSTRALIA (3.45M shares), AQR CAPITAL MANAGEMENT LLC (1.52M shares), VANGUARD GROUP INC (1.47M shares), BlackRock Inc. (1.29M shares), HSBC HOLDINGS PLC (639K shares), STATE STREET CORP (630K shares), DIMENSIONAL FUND ADVISORS LP (574K shares), and NORTHERN TRUST CORP (427K shares).
This table shows the top 124 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.